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Introduction {#sec005}
============

The measurement of intraocular pressure (IOP) is an important means to detect and manage glaucoma \[[@pone.0169438.ref001], [@pone.0169438.ref002]\]. The gold standard for IOP measurement still is Goldmann applanation tonometry (GAT). There are multiple sources of error that may influence the accuracy of GAT measurements \[[@pone.0169438.ref003], [@pone.0169438.ref004]\]. One of the known phenomena is the reduction of the IOP through repeated applanation, also called "tonographic effect" \[[@pone.0169438.ref005]--[@pone.0169438.ref011]\]. Stocker \[[@pone.0169438.ref005]\] mentions the amount of aqueous humor pressed out of the anterior chamber as one of the reasons for the IOP drop. However, he hypothesized that the mechanic process of forcing out the aqueous humor alone cannot explain the tonographic phenomenon, but suspected a reflectory change of aqueous formation as a further variable. Moses \[[@pone.0169438.ref006]\] suspected topical anesthetics as being relevant for the tonographic effect.

In order to increase the measurement reliability in clinical trials, a mean value of several repeated IOP-measurements is used \[[@pone.0169438.ref012]--[@pone.0169438.ref015]\]. Likewise, young ophthalmologists or optometrists at the beginning of their learning curve often need more tries to measure IOP properly. However, repeated GAT measurements bear the risk of false results through the tonographic effect.

Ocular Response Analyzer (ORA) is an IOP measurement technique, which utilizes a visco-elastic structure of the human corneal tissue in a non-contact way. ORA provides both: IOP and biomechanical properties of the cornea such as corneal hysteresis (CH) and corneal resistance factor (CRF). A corneal-compensated intraocular pressure (IOPcc) has been reported to be less affected by the corneal properties than GAT \[[@pone.0169438.ref016]--[@pone.0169438.ref018]\]. Furthermore, CH and CRF seem to be predictors for the development of glaucoma \[[@pone.0169438.ref019]\]. The lack of contact with the cornea eliminates the need for topical anesthetics and reduces the risk of cross-infection and corneal damage \[[@pone.0169438.ref020]--[@pone.0169438.ref022]\].

The ORA-measurements have shown to be reproducible in several studies \[[@pone.0169438.ref017], [@pone.0169438.ref018], [@pone.0169438.ref023]\]. There are only few studies evaluating an influence of repeated ORA measurements or ocular massage on the IOP in healthy subjects \[[@pone.0169438.ref017], [@pone.0169438.ref024], [@pone.0169438.ref025]\].

The purpose of our prospective, randomized clinical trial was to compare ORA and GAT regarding the tonographic effect in glaucoma patients and in healthy controls. Furthermore, we wanted to evaluate the possible correlation between the tonographic effect and parameters as central corneal thickness (CCT), anterior chamber volume (ACV), anterior chamber depth (ACD), CH, and CRF.

Materials and Methods {#sec006}
=====================

This prospective, randomized, single-center, open, controlled study with two parallel study groups was carried out in accordance with the Declaration of Helsinki. Ethics approval was obtained from the Ethics committee of Rhineland-Palatinate, Germany.

Glaucoma patients were recruited from the glaucoma section of the Department of Ophthalmology of the University Medical Center of the Johannes Gutenberg-University Mainz. In order to obtain similar study groups, sex- and age-matched healthy controls were recruited from the staff of the University Medical Center of Mainz and from the patients of a family practice in Mainz, Germany. After a detailed personal survey conversation, a written informed consent was obtained from all study participants. All subjects were then evaluated at the Department of Ophthalmology of the University Medical Center of the Johannes Gutenberg-University Mainz between December 2013 and March 2015. Inclusion criteria for both groups were: female or male of any race aged 18 years or older, ability to understand the character and individual consequences of the clinical trial, signed and dated informed consent must have been available before the start of any specific trial procedure; in the control group: normal ophthalmological status, no glaucoma or other relevant eye diseases, IOP ≤ 21 mmHg; in the patients´ group: diagnosis of primary open-angle glaucoma (POAG), pseudoexfoliation glaucoma (PEXG) or pigment dispersion glaucoma (PG) with characteristic alterations of the optic nerve head and correlating visual field deficiencies.

The exclusion criteria in both groups were: astigmatism \> 2.0 diopters; spherical refraction \> 3.0 diopters; CCT \< 500 μm; CCT \> 600 μm; pseudophakia; corneal, conjunctival, or intraocular inflammatory eye disease; use of contact lenses within three months before study examination; any corneal pathologic condition; history of previous ocular surgery.

Study procedure {#sec007}
---------------

All subjects underwent an assessment of an objective refraction, the best corrected visual acuity (BCVA) with Snellen charts, a slit lamp examination and indirect ophthalmoscopy in miosis.

Each eye underwent nine measurements of the IOP, with both GAT and ORA. The number of IOP measurements differed according to the examination scheme that was assigned in a randomized order to each patient or healthy control ([Table 1](#pone.0169438.t001){ref-type="table"}). For instance, in scheme 1, the left eye (OS) was measured first with triple ORA, triple GAT, and then triple ORA again. Afterwards, the right eye (OD) was measured with triple GAT, triple ORA, and then triple GAT. The time lapse between measurements with different devices was kept as short as possible, i.e. between 25--130 seconds, depending on the mobility of the patients or individual positioning difficulties.

10.1371/journal.pone.0169438.t001

###### Four examination schemes for IOP measurements.

![](pone.0169438.t001){#pone.0169438.t001g}

  Scheme   1st Eye   Period 1   Period 2   Period 3   2nd Eye   Period 1   Period 2   Period 3
  -------- --------- ---------- ---------- ---------- --------- ---------- ---------- ----------
  **1**    OS        ORA        GAT        ORA        OD        GAT        ORA        GAT
  **2**    OS        GAT        ORA        GAT        OD        ORA        GAT        ORA
  **3**    OD        ORA        GAT        ORA        OS        GAT        ORA        GAT
  **4**    OD        GAT        ORA        GAT        OS        ORA        GAT        ORA

ORA, Ocular Response Analyzer; GAT, Goldmann applanation tonometry; OD, right eyes; OS, left eyes.

GAT was performed by one experienced ophthalmologist and the same calibrated tonometer was used through the whole study. ORA- and Pentacam measurements were performed by a medical student, who was experienced and trained in handling of these devices. The measurement of IOP with GAT required instilling [oxybuprocaine-HCl](http://www.gelbe-liste.de/pharmindex/wirkstoff/oxybuprocain-hcl/22244/)/[fluorescein-Na](http://www.gelbe-liste.de/pharmindex/wirkstoff/fluorescein-na/42004/) (Thilorbin®, OmniVision) eye drops in the lower conjunctival cul-de-sac in both eyes and was performed without pupil dilatation in all cases. The application of one anesthetizing eye drop was performed once per eye, regardless of whether the eye was measured with GAT once or twice. Each GAT measurement was performed three times and the mean value was taken for the statistical analysis.

The ORA (Reichert Inc., Depew, USA, software version 2.0) utilizes a visco-elastic structure of the human corneal tissue in a dynamic bi-directional applanation process. The difference in inward and outward pressure values is called CH and the average of both values provides Goldmann-correlated intraocular pressure (IOPg). Calculated on the basis of the measured CH, the ORA provides two other parameters: CRF and IOPcc. According to our study protocol, three measurements were performed and the value with the best wave-score was taken for the statistical analysis.

The Pentacam (Oculus Pentacam HR Typ 70900, Oculus, Weimar, Germany) is a device combining a slit illumination and Scheimpflug camera, which rotate together around the eye. The CCT, ACD and ACV were assessed before and after the IOP session. The average of three values was taken for further analysis.

Statistical analysis {#sec008}
--------------------

The sample size was chosen such that six pairwise t-tests could be performed on a 5% significance level, controlling for multiple testing by using a Bonferroni correction, i.e. a significance level of 0.83% for six pairwise t-tests. A power of 81% was calculated for 70 study participants in order to be able to detect an IOP difference of 1 mmHg with a standard deviation of 3 mmHg. The statistical analysis was performed using Microsoft Excel 2007, IBM SPSS Statistics Version 20, and SAS 9.4. First, descriptive were obtained, i.e. absolute and relative frequencies for categorical variables, mean, standard deviation, minimum, maximum, median and quartiles for quantitative variables. Second, six confirmatory t-tests were performed to identify differences between measurements taken before and after ORA and GAT and between glaucoma patients and probands. The results of these confirmatory t-tests were complemented with a three-period crossover analysis employing a linear model. Moreover, several exploratory t-tests concerning IOP and corneal differences between glaucoma patients and probands were performed.

The Pearson correlation coefficient was used to assess correlations between IOP values (GAT-IOP, IOPg, IOPcc), corneal parameters (CH, CRF), and Pentacam measurements (CCT, ACV and ACD). A correlation coefficient ≥ 0.7 was considered a strong correlation; ≥ 0.5 was considered a moderate correlation; and \< 0.5 a weak correlation.

Results {#sec009}
=======

Both eyes of 31 glaucoma patients (21 female, aged 63.3 ± 8.2 years, range = 40--75 years) and sex- and age-matched 35 healthy probands (21 female, aged 65.2 ± 9.2 years, range = 44--84 years) were enrolled in this study. Originally, 35 patients were included. However, four patients were excluded after measurement values did not meet the inclusion criteria. Thirty patients were diagnosed with primary open angle glaucoma (POAG), while one patient was diagnosed with pseudoexfoliation glaucoma (PEXG). All patients and probands were phakic. All glaucoma patients were treated with topical antiglaucoma agents.

IOP values {#sec010}
----------

Concerning mean GAT-IOP, IOPg, IOPcc, no differences between patients and healthy controls were identified ([Table 2](#pone.0169438.t002){ref-type="table"}). In the case of multiple measurement sessions for the same eye, the mean of these sessions was employed.

10.1371/journal.pone.0169438.t002

###### Mean IOP values ± standard deviation.
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             GAT-IOP OD     GAT-IOP OS     IOPcc OD       IOPcc OS       IOPg OD        IOPg OS
  ---------- -------------- -------------- -------------- -------------- -------------- --------------
  Patients   13.86 ± 3.39   13.47 ± 3.19   16.23 ± 4.35   16.43 ± 4.18   14.32 ± 4.44   15.16 ± 5.01
  Probands   13.90 ± 3.44   14.71 ± 2.66   16.40 ± 4.96   16.14 ± 4.53   15.95 ± 4.29   16.58 ± 4.56
  p-value    0.960          0.091          0.881          0.788          0.134          0.231

GAT-IOP, Goldmann applanation tonometry; IOPcc, corneal-compensated IOP; IOPg, Goldmann-correlated IOP; OD, right eyes; OS, left eyes; in mmHg.

GAT-IOP was systematically lower than IOPcc: mean differences between IOPcc and GAT-IOP of 2.44 ± 3.07 mmHg for OD (p \< 0.001) and 2.15 ± 3.37 mmHg for OS (p \< 0.001) were found.

IOPcc, IOPg and GAT showed no differences between the right and the left eyes.

Tonographic effect {#sec011}
------------------

The significant mean IOP decrease from the first to the second GAT measurement was -0.87 ± 1.77 mmHg, p \< 0.001 in the same eye for patients and probands. This was also confirmed by the results of the linear model. The average difference between the first and the second mean GAT-IOP was -0.55 ± 2.00 mmHg (p = 0.138) for the glaucoma patients and -1.15 ± 1.52 mmHg (p \< 0.001) for controls ([Fig 1](#pone.0169438.g001){ref-type="fig"}). No significant difference between glaucoma patients and healthy probands concerning the magnitude of the tonographic effect could be found (p = 0.196).

![Tonographic effect from the first (GAT-IOP 1) to the second (GAT-IOP 2) GAT measurement for patients, probands and the overall sample (patients and probands combined), \[mmHg\].](pone.0169438.g001){#pone.0169438.g001}

The mean difference between the first and the second IOPcc for both study groups combined was -0.43 ± 3.17 mmHg (p = 0.276), thus being non-significant. This was also confirmed by the results of the linear model. The average difference between the first and the second IOPcc was -0.11 ± 3.06 mmHg in patients (p = 0.843) and -0.71 ± 3.28 mmHg for controls (p = 0.208), no significant difference between patients and probands could be found (p = 0.446) ([Fig 2](#pone.0169438.g002){ref-type="fig"}).

![Tonographic effect from the first (IOPcc 1) to the second (IOPcc 2) IOPcc measurement for patients, probands and the overall sample (patients and probands combined), \[mmHg\].](pone.0169438.g002){#pone.0169438.g002}

The mean difference between the first and the second IOPg was -0.31.± 2.35 mmHg, (p = 0.285) for both groups combined (non-significant). This was also confirmed by the results of the linear model. The average difference between the first and the second IOPg was -0.31± 2.38 mmHg (p = 0.469) in glaucoma patients and -0.31 ± 2.37 mmHg (p = 0.441) in controls. There was no significant difference between patients and probands (p = 0.998) ([Fig 3](#pone.0169438.g003){ref-type="fig"}).

![Tonographic effect from the first (IOPg 1) to the second (IOPg 2) IOPg measurement for patients, probands and the overall sample (patients and probands combined), \[mmHg\].](pone.0169438.g003){#pone.0169438.g003}

Pentacam parameters {#sec012}
-------------------

Mean CCT was noticeably thinner in glaucoma patients in comparison to healthy controls in both measurements in both eyes ([Table 3](#pone.0169438.t003){ref-type="table"}).

10.1371/journal.pone.0169438.t003

###### Mean values and standard deviations of central corneal thickness before and after IOP measurements for patients and probands.
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             CCT 1_OD         CCT 1_OS         CCT 2_OD         CCT 2_OS
  ---------- ---------------- ---------------- ---------------- ----------------
  Patients   538.46 ± 19.65   535.74 ± 20.03   541.05 ± 20.31   541.63 ± 18.99
  Probands   556.20 ± 24.34   557.56 ± 24.49   564.48 ± 25.44   562.02 ± 26.48
  p-value    0.002            \< 0.001         \< 0.001         0.001

CCT, central corneal thickness; CCT 1, CCT before IOP measurements; CCT 2, CCT after IOP measurements; OD, right eyes; OS, left eyes; μm.

The repeated GAT/ORA IOP measurements led to a relevant increase of CCT in all subjects ([Table 4](#pone.0169438.t004){ref-type="table"}).

10.1371/journal.pone.0169438.t004

###### Mean values and standard deviations for differences between first and second CCT measurements.
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               CCT1_2\_OD    CCT1_2\_OS
  ------------ ------------- -------------
  Value ± SD   5.61 ± 9.41   5.13 ± 7.39
  p-value      \< 0.001      \< 0.001

SD, standard deviation; CCT1_2, mean values and SDs for differences between first and second CCT measurements; OD, right eyes; OS, left eyes; μm.

ACV and ACD did not differ between patients and probands ([Table 5](#pone.0169438.t005){ref-type="table"}). The repeated IOP-measurements did not influence the ACD in both eyes and ACV in the right eyes. Only the ACV in the left eyes showed a decrease between the first and the second Pentacam measurement (p = 0.02).

10.1371/journal.pone.0169438.t005

###### Anterior chamber volume and anterior chamber depth before and after repeated GAT/ORA IOP measurements for patients and probands for the right and the left eyes.
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             ACV 1_OD         ACV 1_OS         ACV 2_OD         ACV 2_OS         ACD 1_OD      ACD 1_OS      ACD 2_OD      ACD 2_OS
  ---------- ---------------- ---------------- ---------------- ---------------- ------------- ------------- ------------- -------------
  Patients   142.65 ± 32.67   140.18 ± 33.00   141.59 ± 32.73   140.02 ± 33.43   2.66 ± 0.33   2.67 ± 0.31   2.65 ± 0.33   2.66 ± 0.33
  Probands   129.60 ± 34.54   132.74 ± 33.42   128.74 ± 32.37   130.55 ± 31.08   2.55 ± 0.39   2.57 ± 0.38   2.55 ± 0.38   2.57 ± 0.38
  p-value    0.121            0.367            0.114            0.238            0.241         0.255         0.265         0.325

ACV, anterior chamber volume \[mm^3^\]; ACD, anterior chamber depth \[mm\]; ACV 1/ACD 1, values before repeated GAT/ORA measurements; ACV 2/ACD 2, values after repeated GAT/ORA IOP measurements; OD, right eyes; OS, left eyes.

Crossover model {#sec013}
---------------

The confirmatory t-tests verify the results of the three period crossover analyses, with GAT values on average at 1.98 mmHg (p = 0.0028) lower than IOPcc values (95% CI: \[-3.26, -0.69\]). When comparing IOPcc (ORA) with GAT we found no carry-over effects (p = 0.29), we also found no period effect (p = 0.29). However, we found a significant treatment effect. Therefore, still no tonographic effect could be observed for the ORA measurements. No difference was found for a right versus left eye comparison.

Discussion {#sec014}
==========

In order to find out whether the tonographic effect concerns ORA measurements, we employed a cross-over analysis with multiple GAT and ORA IOP-measurements randomly alternating between the right and the left eyes of healthy controls and glaucoma patients. In contrast to GAT, we did not find any significant decrease of IOPcc and IOPg between the first and the second ORA measurement and therefore no statistically or clinically significant tonographic effect in either glaucoma patients or healthy controls. Only two studies report about the effect of repeated ORA measurements on IOP: Goebels et al. \[[@pone.0169438.ref024]\] found IOPcc and IOPg values decreasing by -1.05 and -1.19 mmHg within a sequence of five sequential ORA readings in healthy subjects. This effect was more pronounced than in the healthy population of our study (-0.71 ± 3.28 mmHg, p = 0.208 for IOPcc and -0.31 ± 2.37 mmHg, p = 0.441, for IOPg). This may be explained by a higher number of single ORA measurements (5 sets with 4 readings each) or by the younger age of their population (mean 35 years, range 17--59 years) compared to the age of our healthy population (65.2 years, range 44--84 years). Corneal stiffness was shown to increase with age \[[@pone.0169438.ref026]--[@pone.0169438.ref032]\]. However, the authors do not mention any significances or the time intervals between the ORA measurements, thus making comparisons difficult. David et al. \[[@pone.0169438.ref017]\] compared 12 readings (3 sets with 4 readings each) of ORA parameters (IOPcc, IOPg, CH, and CRF) obtained within a 30-minute period in healthy subjects. They found significantly higher IOPcc and IOPg values in the first set of measurements compared to later readings with a maximum difference of -0.52 mmHg (p = 0.01) for IOPcc and -0.49 mmHg (p = 0.004) for IOPg (difference between sessions one and two for right eyes). Lam and Chen \[[@pone.0169438.ref025]\] evaluated the effect of ocular massage on ORA parameters in young healthy subjects, finding a significant decrease of IOPcc of about 2.8 mmHg. As important ameliorations, our study compared ORA results with GAT and took wave score as a quality criterion into consideration. A purpose-built additional three period cross-over analysis helped to detect any tonographic effects. Moreover, to the best of our knowledge our study examined the tonographic effect of ORA for the first time in glaucoma patients and in age-matched controls.

There have been only few attempts to determine the tonographic effect for other non-contact tonometers \[[@pone.0169438.ref011], [@pone.0169438.ref033]\]. Al-Mubrad and Ogbuehi \[[@pone.0169438.ref034]\] examined the tonographic effect of Keeler Pulsair EasyEye and Topcon CT80 in 120 healthy subjects by using a randomized examination scheme with different combinations of CT80, Keeler and GAT, measuring three times (Keeler, GAT) or four times (CT80). They found an IOP-decrease of -1.0 ± 2.3 mmHg (p \< 0.05) for Keeler Pulsair EasyEye and -0.6 ± 1.7 mmHg (p \< 0.05) for Topcon CT80 in healthy subjects and therefore a statistically significant tonographic effect.

GAT-IOP was systematically lower in comparison to IOPcc in our study. Similar results were found by several researchers \[[@pone.0169438.ref012], [@pone.0169438.ref014], [@pone.0169438.ref035]--[@pone.0169438.ref041]\]. With regard to mean GAT-IOP, IOPcc and IOPg values, no differences could be found between patients and healthy probands. The fact that all glaucoma patients were using IOP-lowering medications at the time of the study might explain the lack of IOP differences between patients and probands. The phenomenon of similar IOP values between glaucoma patients under therapy and probands can be observed in other studies such as these of Costin et al. \[[@pone.0169438.ref042]\] or Sullivan-Mee et al. \[[@pone.0169438.ref019]\].

In our study we found a statistically significant tonographic effect of GAT. We recorded the GAT-IOP reduction of mean -0.55 ± 2.00 mmHg for glaucoma patients and -1.15 ± 1.52 mmHg for healthy controls. The more pronounced tonographic effect in healthy controls in comparison to glaucoma patients may be explained by a pathologically changed trabecular meshwork of the glaucomatous eyes \[[@pone.0169438.ref043], [@pone.0169438.ref044]\] The time gap between the two GAT measurements was approximately three minutes. Since Stocker \[[@pone.0169438.ref005]\] there have been numerous attempts to analyze the tonographic effect of GAT ([Table 6](#pone.0169438.t006){ref-type="table"}). The study applying a quite similar study design concerning GAT is that of Recep et al. \[[@pone.0169438.ref010]\], who obtained similar GAT-IOP differences after three minutes in healthy subjects after employing oxybuprocaine and fluorescein for GAT-IOP measurement. Our results are also comparable with other mentioned studies. However, they either measured only normal subjects or only glaucomatous patients \[[@pone.0169438.ref005]--[@pone.0169438.ref008], [@pone.0169438.ref045]--[@pone.0169438.ref047]\] or only glaucomatous patients \[[@pone.0169438.ref009]\], or do not give any information about the significance of their results. \[[@pone.0169438.ref008], [@pone.0169438.ref045], [@pone.0169438.ref047]\]. The other works employed a slightly different setting with very short time gaps between GAT-IOP measurements \[[@pone.0169438.ref033], [@pone.0169438.ref048], [@pone.0169438.ref049]\]. Overall, despite the statistical significance of the tonographic effect for GAT-IOP, an IOP change in the range of -0.5 to -1.15 mmHg does not seem to have decisive relevance in a clinical setting.

10.1371/journal.pone.0169438.t006

###### Overview of the studies analyzing the tonographic effect of contact and non-contact tonometers.
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  Author(s)                                       Year   IOP/IOP change                                                 Sig. (p)    Setup                                                                                                                         Sample (n)   Eye status     Device
  ----------------------------------------------- ------ -------------------------------------------------------------- ----------- ----------------------------------------------------------------------------------------------------------------------------- ------------ -------------- ------------------------
  Stocker \[[@pone.0169438.ref005]\]              1958   -0.97 mmHg                                                     n.a.        30s after first reading on same eye                                                                                           20           normal         Schiötz tonometer
                                                         -1.90 mmHg                                                     n.a.        4 mins after first reading on same eye                                                                                        20           normal         
                                                         -2.72 mmHg                                                     n.a.        4 mins after the tonometer resting on other eye                                                                               20           normal         
                                                         -2.37 mmHg                                                     n.a.        on healthy eyes                                                                                                               12           normal         
                                                         -3.25 mmHg                                                     n.a.        on glaucomatous eyes                                                                                                          8            glaucomatous   
  Armaly & Rubin \[[@pone.0169438.ref037]\]       1961   -0.26 ± 0.75 to -0.39 ± 0.81 mmHg                              sig.        GAT values after GAT once a minute for six minutes                                                                            20           normal         GAT
  Moses \[[@pone.0169438.ref006]\]                1961   -0.9 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        1 min after first reading on right eye                                                                                        25           normal         GAT
                                                         +0.1 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        2 mins after first reading on right eye                                                                                       25                          
                                                         -1 mmHg[\*](#t006fn001){ref-type="table-fn"}                   n.a.        3 mins after first reading on right eye                                                                                       25                          
                                                         -0.05 mmHg[\*](#t006fn001){ref-type="table-fn"}                n.a.        4 mins after first reading on right eye                                                                                       25                          
                                                         -0.9 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        5 mins after first reading on right eye                                                                                       25                          
                                                         -0.1 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        1 min after first reading on left eye, 7 mins after first reading on right eye                                                25                          
                                                         +0.1 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        2 mins after first reading on left eye, 8 mins after first reading on right eye                                               25                          
                                                         -0.5 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        3 mins after first reading on left eye, 9 mins after first reading on right eye                                               25                          
                                                         -0.4 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        4 mins after first reading on left eye, 10 mins after first reading on right eye                                              25                          
                                                         -0.1 mmHg[\*](#t006fn001){ref-type="table-fn"}                 n.a.        5 mins after first reading on left eye, 11 mins after first reading on right eye                                              25                           
  Bechrakis \[[@pone.0169438.ref009]\]            1966   -3.70 mmHg                                                     n.a.        4 mins after first reading on same eye                                                                                        17           glaucomatous   GAT
                                                         -5.7 ± 1.3 mmHg                                                n.a.        12 mins after first reading on same eye                                                                                       17                          
                                                         -5.1 mmHg                                                      n.a.        12 mins after first reading on same eye                                                                                       17                          
                                                         -3.58 ± 1.2 mmHg                                               n.a.        4 mins after first reading on same eye                                                                                        44                           
  Moses & Liu \[[@pone.0169438.ref039]\]          1968   -0.40 ± 1.40 mmHg                                              \< 0.05     right eye, rising and approx. 30 feet of walking between measurements                                                         74           glaucomatous   GAT
                                                         -0.16 ± 1.43 mmHg                                              n.a.        left eye, rising and approx. 30 feet of walking between measurements                                                          74                           
  Krakau & Wilke \[[@pone.0169438.ref007]\]       1971   -2.9 mmHg                                                      n.a.        5 mins after the first measurement and one measurement each minute on the same eye                                            16           normal         GAT
                                                         -4.6 mmHg                                                      n.a.        5 mins after the first measurement and one measurement each minute on the same eye                                            5                            
  Wilke \[[@pone.0169438.ref008]\]                1972   -0.4 mmHg                                                      \> 0.10     A\) 5 mins on the same eye after measurement on both eyes                                                                     6            normal         GAT
                                                         -2.6 mmHg                                                      \< 0.001    B\) 5 minutes on the same eye after measurement once a minute for 5 minutes                                                   6                           
                                                         -3.2 mmHg                                                      \< 0.001    C\) Patients seated for 5 mins after having local anesthesia, then measurements as in B)                                      6                           
                                                         -2.9 mmHg                                                      \< 0.001    Sham measurements without contact to cornea, then as in B)                                                                    6                            
  Phelps & Phelps \[[@pone.0169438.ref036]\]      1976   -0.4 ± 2.6 mmHg                                                \< 0.05     Mean IOP change in the right eye after 15 (5--30 minutes range) minutes of walking                                            210          normal         GAT
                                                         -0.2 ± 2.4 mmHg                                                \> 0.05     Mean IOP change in the left eye after 15 (5--30 minutes range) minutes of walking                                             210                          
  Thorburn \[[@pone.0169438.ref038]\]             1979   -0.5 ± 0.9 mmHg                                                n.a.        IOP change with same investigator, time interval unclear                                                                      20           in-patients    GAT
                                                         -0.5 ± 0.9 mmHg                                                n.a.        IOP change with two different investigators for 1st and 2nd measurement, time interval unclear                                72                           
  Motolko et al.                                  1982   18.81 mmHg                                                                 Mean of first three GAT measurements in 30s intervals                                                                         9            normal         GAT
  \[[@pone.0169438.ref035]\]                             17.48 mmHg                                                     \< 0.05     Mean of fourth through sixth GAT mesaurement in 30s intervals                                                                 9                           
                                                         16.78 mmHg                                                     \< 0.05     Mean of seventh through ninth GAT measurement in 30s intervals                                                                9                            
  Recep et al. \[[@pone.0169438.ref010]\]         1998   -1.33 ± 1.86 mmHg                                              \< 0.05     1 min on the same eye after first measurement                                                                                 34           normal         GAT
                                                         -0.53 ± 1.78 mmHg                                              \> 0.05     2 mins on the same eye after first measurement                                                                                29                          
                                                         -1.89 ± 1.57 mmHg                                              \< 0.05     3 mins on the same eye after first measurement                                                                                27                          
                                                         -2.29 ± 1.07 mmHg                                              \< 0.05     4 mins on the same eye after first measurement                                                                                41                          
                                                         -1.92 ± 2.08 mmHg                                              \< 0.05     5 mins on the same eye after first measurement                                                                                33                          
                                                         -0.00 ± 1.17 mmHg                                              \> 0.05     10 mins on the same eye after first measurement                                                                               28                           
  Stewart et al. \[[@pone.0169438.ref040]\]       2004   IOP 1) 24.9 ± 2.7, IOP 2) 25.0 ± 2.8, IOP 3) 24.9 ± 2.8 mmHg   \> 0.05     3 IOP readings of untreated baseline IOPs within a few seconds at 8 am                                                        33           glaucomatous   GAT
                                                         IOP 1) 16.3 ± 2.9, IOP 2)16.1 ± 3.0, IOP 3) 16.3 ± 2.9 mmHg    \> 0.05     3 IOP readings of treated final IOPs within a few seconds at 8 am                                                             33                          
  Lam et al. \[[@pone.0169438.ref025]\]           2007   1\) 15.32 ± 2.30 2) 12.56 ± 3.08                               sig.        IOPcc before (1) and after (2) ocular massage for 5 mins                                                                      53           normal         ORA
                                                         1\) 11.03 ± 1.31 2) 11.63± 1.46                                sig.        CH before (1) and after (2) ocular massage for 5 mins                                                                         53                          
                                                         1\) 10.96 ± 1.60 2) 10.72 ± 1.65                               sig.        CRF before (1) and after (2) ocular massage for 5 mins                                                                        53                          
                                                         \> +1.00 mmHg                                                  n.a.        Distribution of change in IOPcc from ocular massage                                                                           2                           
                                                         +1.00 to -1.00 mmHg                                            n.a.        Distribution of change in IOPcc from ocular massage                                                                           11                          
                                                         -1.01 to -3.00 mmHg                                            n.a.        Distribution of change in IOPcc from ocular massage                                                                           14                          
                                                         -3.01 to -5.00 mmHg                                            n.a.        Distribution of change in IOPcc from ocular massage                                                                           18                          
                                                         \> -5.00 mmHg                                                  n.a.        Distribution of change in IOPcc from ocular massage                                                                           8                            
  AlMubrad & Ogbuehi \[[@pone.0169438.ref023]\]   2010   1.0 ± 2.3 mmHg                                                 \< 0.05     IOP difference before and after GAT, min. 48 hrs between sessions, interval between GAT and non-contact tonometry 2--5 mins   60           normal         Keeler Pulsair EasyEye
                                                         0.6 ± 1.7 mmHg                                                 \< 0.05     IOP difference before and after GAT, min. 48 hrs between sessions, interval between GAT and non-contact tonometry 2--5 mins   60                          Topcon CT80
  Gaton et al. \[[@pone.0169438.ref026]\]         2010   IOP 1) 15.94 ± 4.3 mmHg                                        \< 0.0001   GAT readings in interval of few seconds                                                                                       67           glaucomatous   GAT
                                                         IOP 2) 14.90 ± 4.5 mmHg                                                    67                                                                                                                                                        
                                                         IOP 1) 13.64 ± 3.8 mmHg                                        0.83        GAT readings in interval of few seconds                                                                                       70           normal         
                                                         IOP 2) 13.73 ± 3.2 mmHg                                                    70                                                                                                                                                        
  Goebels et al. \[[@pone.0169438.ref024]\]       2012   14.92 mmHg                                                     \-          Mean IOPcc measurement 1                                                                                                      45           normal         ORA
                                                         14.14 mmHg                                                     \-          Mean IOPcc measurement 2                                                                                                      45                          
                                                         13.78 mmHg                                                     \-          Mean IOPcc measurement 3                                                                                                      45                          
                                                         13.91 mmHg                                                     \-          Mean IOPcc measurement 4                                                                                                      45                          
                                                         13.87 mmHg                                                     \-          Mean IOPcc measurement 5                                                                                                      45                          
                                                         15.72 mmHg                                                     \-          Mean IOPg measurement 1                                                                                                       45                          
                                                         14.92 mmHg                                                     \-          Mean IOPg measurement 2                                                                                                       45                          
                                                         14.49 mmHg                                                     \-          Mean IOPg measurement 3                                                                                                       45                          
                                                         14.58 mmHg                                                     \-          Mean IOPg measurement 4                                                                                                       45                          
                                                         14.53 mmHg                                                     \-          Mean IOPg measurement 5                                                                                                       45                           
  David et al. \[[@pone.0169438.ref017]\]         2013   -0.493 mmHg                                                    0.004       IOPg difference between sessions 1 and 2, right eyes                                                                          100          normal         ORA
                                                         -0.241 mmHg                                                    0.08        IOPg difference between sessions 1 and 2, left eyes                                                                           100                         
                                                         -0.521 mmHg                                                    0.01        IOPcc difference between sessions 1 and 2, right eyes                                                                         100                         
                                                         -0.269 mmHg                                                    0.11        IOPcc difference between sessions 1 and 2, left eyes                                                                          100                         
                                                         0.011 mmHg                                                     0.93        IOPg difference between sessions 2 and 3, right eyes                                                                          100                         
                                                         -0.168 mmHg                                                    0.10        IOPg difference between sessions 2 and 3, left eyes                                                                           100                         
                                                         0.141 mmHg                                                     0.43        IOPcc difference between sessions 2 and 3, right eyes                                                                         100                         
                                                         -0.148 mmHg                                                    0.35        IOPcc difference between sessions 2 and 3, left eyes                                                                          100                         
                                                         -0.482 mmHg                                                    0.002       IOPg difference between sessions 1 and 3, right eyes                                                                          100                         
                                                         -0.409 mmHg                                                    0.008       IOPg difference between sessions 1 and 3, left eyes                                                                           100                         
                                                         -0.380 mmHg                                                    0.03        IOPcc difference between sessions 1 and 3, right eyes                                                                         100                         
                                                         -0.417 mmHg                                                    0.02        IOPcc difference between sessions 1 and 3, left eyes                                                                          100                          

\* IOP estimations as observed in graphic.

Another aspect of this study was to analyze whether a correlation between corneal parameters and the tonographic effect exists. We identified a weak (r = 0.37), but mentionable (p = 0.042) correlation between the tonographic effect of GAT and CCT. This was true only for patients, but not for the healthy controls (r = -0.107). To the best of our knowledge, we executed the only study that evaluated the relationship of CCT with the GAT-IOP change, i.e. the tonographic effect for glaucomatous eyes. We can speculate, the higher the initial CCT, the higher the tonographic effect in glaucoma patients or vice versa. Baseline CCT was thinner in glaucoma patients in comparison to healthy controls. Similar effects were found by other authors either \[[@pone.0169438.ref034], [@pone.0169438.ref041], [@pone.0169438.ref042], [@pone.0169438.ref046], [@pone.0169438.ref047]--[@pone.0169438.ref050]\].

Repeated IOP-measurements resulted in a noticeable increase of CCT, but no change of the anterior chamber depth and volume. Ocular massage through applanation tonometry might cause damage to the corneal epithelium and thus soften structures and/or increase penetration of anesthetics \[[@pone.0169438.ref003], [@pone.0169438.ref022]\]. This might be crucial for a CCT change as well: Al-Mubrad and Ogbuehi \[[@pone.0169438.ref020]\], p.307, mention a study by Weekers \[[@pone.0169438.ref050]\], stating "that topical anesthetics caused an alteration of the endothelial Na+/K+ pump resulting increased stromal hydration and as a consequence, increased corneal thickness." Herse and Siu \[[@pone.0169438.ref051]\] also suspect the appearance of transitory edema of the corneal stroma as a cause for the CCT increase. Rosa et al. \[[@pone.0169438.ref052]\] mention the preservatives present in the ophthalmic solutions as a trigger for structural/functional damage to both the corneal epithelium and endothelium, thus increasing CCT in other studies. The increased corneal penetration caused by applanation tonometry could explain why a CCT increase with potential edema etc. was observed without any change in ACV or ACD. Moreover, since the restoration of ACV presumably takes between 2--5 minutes, it is very likely that any ACV reduction was compensated for before the final Pentacam measurements \[[@pone.0169438.ref011], [@pone.0169438.ref053]\].

The study has certain limitations: concerning participating glaucoma patients, an inhomogeneous group with supposedly different kinds and numbers of topical medication were included. The differences in medication might have differing effects on corneal properties etc. As a further consequence, only glaucoma patients with normal IOP values were included in the study. Thus, conclusions cannot be drawn for (untreated) glaucoma patients with elevated IOP values.

The results are part of the doctoral thesis of Martin Zimmermann.
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